Fervent Synergies Ltd
Incorporated in 2012, Fervent Synergies Ltd is in the business of food and finance
- Market Cap ₹ 105 Cr.
- Current Price ₹ 20.9
- High / Low ₹ 32.0 / 17.0
- Stock P/E 28.6
- Book Value ₹ 10.8
- Dividend Yield 0.00 %
- ROCE 7.47 %
- ROE 7.47 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Company has a low return on equity of -8.09% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.63 | 3.51 | 3.67 | 39.15 | 5.51 | 16.67 | 7.35 | 2.21 | 0.68 | 4.63 | 24.31 | 32.46 | 33.09 | |
| 0.50 | 0.53 | 0.66 | 36.47 | 4.41 | 15.26 | 6.90 | 1.93 | 0.86 | 4.15 | 37.08 | 29.47 | 29.40 | |
| Operating Profit | 2.13 | 2.98 | 3.01 | 2.68 | 1.10 | 1.41 | 0.45 | 0.28 | -0.18 | 0.48 | -12.77 | 2.99 | 3.69 |
| OPM % | 80.99% | 84.90% | 82.02% | 6.85% | 19.96% | 8.46% | 6.12% | 12.67% | -26.47% | 10.37% | -52.53% | 9.21% | 11.15% |
| -0.04 | 0.00 | -0.07 | 0.83 | 0.06 | 0.41 | 0.03 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.06 | 0.04 | 0.01 | 0.19 | 0.01 | 0.07 | 0.15 | 0.01 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | 1.98 | 2.89 | 2.88 | 3.31 | 1.14 | 1.74 | 0.31 | 0.23 | -0.20 | 0.44 | -12.85 | 2.95 | 3.65 |
| Tax % | 32.83% | 32.53% | 33.68% | 27.19% | 27.19% | 28.74% | 25.81% | 26.09% | 20.00% | 47.73% | 0.00% | 0.00% | |
| 1.33 | 1.95 | 1.91 | 2.41 | 0.83 | 1.23 | 0.24 | 0.17 | -0.24 | 0.23 | -12.84 | 2.95 | 3.66 | |
| EPS in Rs | 0.53 | 0.65 | 0.64 | 0.80 | 0.28 | 0.41 | 0.08 | 0.06 | -0.08 | 0.08 | -4.28 | 0.67 | 0.82 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 35% |
| 3 Years: | 263% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 65% |
| 3 Years: | 143% |
| TTM: | 128% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 4% |
| 3 Years: | 13% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -5% |
| 3 Years: | -8% |
| Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 25.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 43.75 | 50.00 |
| Reserves | 3.49 | 6.44 | 8.34 | 10.75 | 11.80 | 12.78 | 12.58 | 13.04 | 12.99 | 13.22 | 0.38 | 4.89 | 4.15 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| 0.72 | 1.02 | 1.02 | 1.49 | 0.39 | 0.71 | 0.82 | 0.70 | 0.14 | 0.23 | 0.14 | 0.14 | 0.10 | |
| Total Liabilities | 29.21 | 37.46 | 39.36 | 42.24 | 42.19 | 43.49 | 43.40 | 43.74 | 43.13 | 43.45 | 30.52 | 48.78 | 54.28 |
| 0.49 | 0.48 | 0.45 | 1.94 | 3.57 | 17.60 | 17.79 | 17.76 | 16.10 | 16.06 | 7.52 | 7.48 | 7.47 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.00 | 0.00 | 2.16 | 0.00 | 0.97 | 0.72 | 0.28 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 27.72 | 36.98 | 36.75 | 40.30 | 37.65 | 25.17 | 25.33 | 25.41 | 27.03 | 27.39 | 23.00 | 41.30 | 46.81 | |
| Total Assets | 29.21 | 37.46 | 39.36 | 42.24 | 42.19 | 43.49 | 43.40 | 43.74 | 43.13 | 43.45 | 30.52 | 48.78 | 54.28 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.66 | 1.06 | -6.28 | -1.82 | 2.85 | 11.58 | 1.95 | 0.18 | -2.19 | -0.07 | -0.20 | -15.08 | |
| 0.00 | 1.00 | -2.14 | 1.19 | -2.39 | -14.03 | -0.22 | 0.00 | 2.40 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.12 | |
| Net Cash Flow | -3.66 | 8.06 | -8.41 | -0.63 | 0.46 | -2.46 | 1.73 | 0.18 | 0.21 | -0.07 | -0.20 | 0.04 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 42.61 | 46.37 | 66.12 | 131.60 | 289.03 | 0.00 | 47.30 | 0.00 | 0.00 |
| Inventory Days | 12.16 | 0.00 | 0.00 | 80.66 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Days Payable | 0.00 | 0.00 | ||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 54.77 | 46.37 | 66.12 | 212.26 | 289.03 | 0.00 | 47.30 | 0.00 | 0.00 |
| Working Capital Days | 1,992.93 | 1,589.99 | 2,337.19 | 256.20 | 1,437.48 | 248.95 | 482.20 | 3,260.23 | 14,331.62 | 2,132.45 | 344.58 | 463.17 |
| ROCE % | 7.48% | 9.09% | 8.02% | 7.51% | 2.79% | 4.28% | 1.08% | 0.56% | -0.46% | 1.02% | -34.81% | 7.47% |
Documents
Announcements
-
Outcome Of Board Meeting Held On Thursday, 6Th November, 2025
6 Nov - Approved Q2/H1 ended 30/09/2025 unaudited results: Q2 revenue Rs68.40L, Q2 net profit Rs43.35L; limited review Nov 6, 2025.
-
Board Meeting Intimation for Quarterly Results On 6Th November, 2025
29 Oct - Board meeting on 6 Nov 2025 to approve Q2 (30 Sep 2025) unaudited results; trading window closed.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Oct - Certificate under Regulation 74(5) confirming dematerialisation for quarter ended 30 September 2025.
-
Closure of Trading Window
25 Sep - Trading window closed 01-Oct-2025 until 48 hours after unaudited Q2 results for quarter ended 30 Sep 2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
19 Sep - 16th AGM (18 Sep 2025): all resolutions passed; 45,842,571 votes for; director reappointed; secretarial auditor reappointed
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company used to deal in Pharmaceutical and Chemical products, import-export trading and distribution of various chemicals solvents API intermediates & other bulk drugs